Data | COVID group (n = 55) | Non-COVID group (n = 22) | p value | |
---|---|---|---|---|
Age (years) | 62 [54–69] | 61.5 [48–71.5] | 0.99 | |
Sex: male, n (%) | 36 (65.5) | 16 (72.7) | 0.60 | |
Weight, kg | 92 [82–102] | 79 [70–109] | 0.06 | |
BMI (kg/m2) | 31.2 [28.7–33.9] | 27.4 [24–38.8] | 0.20 | |
Medical history, n (%) | Chronic kidney disease | 2 (3.6) | 1 (4.5) | > 0.99 |
Diabetes | 26 (47.3) | 8 (36.4) | 0.38 | |
Hypertension | 31 (56.4) | 18 (81.8) | 0.04 | |
Cardiovascular disease* | 11 [20] | 12 (54.5) | < 0.01 | |
COPD | 11 [20] | 3 (13.6) | 0.74 | |
Asthma | 5 (9.1) | 0 (0) | 0.32 | |
Immunosuppressive treatment | 1 (1.8) | 3 (13.6) | 0.07 | |
Active smoking | 4 (7.4) | 8 (36.4) | < 0.01 | |
Admission type, n (%) | Medical | 55 (100) | 9 (40.9) | < 0.01 |
Admission failure, n (%) | Cardiovascular | 0 | 11 (50) | - |
Pulmonary | 55 (100) | 2 (9) | - | |
Neurologic | 0 | 6 (27) | - | |
Other | 0 | 3 (14) | - | |
SAPS II | 33 [26–40] | 34.5 [25–42] | 0.97 | |
Mechanical ventilation, n (%) | 40 (75.5) | 12 (54.5) | 0.07 | |
Duration of mechanical ventilation, days | 17 [11–25] | 6 [2–14] | < 0.01 | |
Neuromuscular blocking duration, days | 0 [0–4] | 0 [0–0] | 0.08 | |
Prone position, n (%) | 31 (56.4) | 0 (0) | < 0.01 | |
Corticosteroids, n (%) | 40 (72.7) | 3 (13.6) | < 0.01 | |
Insulin infusion duration, days | 0 [0–7] | 0 [0–1.5] | 0.44 | |
CRP peak, mg/L | 284 [189.4–338.7] | 184.2 [149.4–260.8] | 0.02 | |
Glucose peak, mg/dL | 229 [191–320] | 215.5 [173.3–274.5] | 0.22 | |
ICU LOS, days | 15 [9–27] | 13.5 [10–20] | 0.57 | |
Hospital LOS, days | 28 [20–48] | 29.5 [20.2–42.2] | 0.98 |